DAVITA INC. Goodwill, Translation and Purchase Accounting Adjustments
DAVITA INC. (DVA) reported Goodwill, Translation and Purchase Accounting Adjustments of $11.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments · last filed 2026-08-04
- DAVITA INC. goodwill, translation and purchase accounting adjustments for the quarter ending 2026-06-30 was -$86.93M, a 274.08% decline year-over-year.
- DAVITA INC. goodwill, translation and purchase accounting adjustments for the quarter ending 2026-03-31 was $98.19M, a 145.82% increase year-over-year.
- DAVITA INC. goodwill, translation and purchase accounting adjustments for the quarter ending 2025-12-31 was -$1.70M.
- DAVITA INC. goodwill, translation and purchase accounting adjustments for the quarter ending 2025-09-30 was $10.02M, a 61.40% decline year-over-year.
| Period end | Goodwill, Translation and Purchase Accounting Adjustments 3 month | Goodwill, Translation and Purchase Accounting Adjustments 3 month as first filed | Goodwill, Translation and Purchase Accounting Adjustments 6 month | Goodwill, Translation and Purchase Accounting Adjustments 9 month | Goodwill, Translation and Purchase Accounting Adjustments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$86.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $11.26M 10-Q · filed 2026-08-04 | $9.56M derived: sum of 3 quarters · filed 2026-08-04 | $19.57M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $98.19M 10-Q · filed 2026-08-04 | $6.58M 10-Q · filed 2026-05-05 | $96.49M derived: sum of 2 quarters · filed 2026-08-04 | $106.51M derived: sum of 3 quarters · filed 2026-08-04 | $156.44M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$1.70M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-05 | $8.31M derived: sum of 2 quarters · filed 2026-05-05 | $58.25M derived: sum of 3 quarters · filed 2026-05-05 | $98.19M 10-Q · filed 2026-05-05 | |
| 2025-09-30 | $10.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $59.95M derived: sum of 2 quarters · filed 2025-10-29 | $99.90M 10-Q · filed 2025-10-29 | $38.02M derived: sum of 4 quarters · filed 2025-10-29 | |
| 2025-06-30 | $49.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $89.88M 10-Q · filed 2025-08-05 | $28.01M derived: sum of 3 quarters · filed 2025-10-29 | $53.95M derived: sum of 4 quarters · filed 2025-10-29 | |
| 2025-03-31 | $39.95M 10-Q · filed 2025-05-12 | -$21.93M derived: sum of 2 quarters · filed 2025-10-29 | $4.02M derived: sum of 3 quarters · filed 2025-10-29 | -$24.81M derived: sum of 4 quarters · filed 2025-10-29 | |
| 2024-12-31 | -$61.88M derived: 10-Q 12 month − 10-Q 9 month · filed 2025-10-29 | -$35.93M derived: sum of 2 quarters · filed 2025-10-29 | -$64.76M derived: sum of 3 quarters · filed 2025-10-29 | -$83.22M 10-Q · filed 2025-10-29 | |
| 2024-09-30 | $25.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$2.88M derived: sum of 2 quarters · filed 2024-10-29 | -$21.34M 10-Q · filed 2024-10-29 | $8.04M derived: sum of 4 quarters · filed 2024-10-29 | |
| 2024-06-30 | -$28.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$47.29M 10-Q · filed 2024-08-06 | -$17.91M derived: sum of 3 quarters · filed 2024-10-29 | -$39.92M derived: sum of 4 quarters · filed 2024-10-29 | |
| 2024-03-31 | -$18.46M 10-Q · filed 2024-05-02 | $10.92M derived: sum of 2 quarters · filed 2024-10-29 | -$11.09M derived: sum of 3 quarters · filed 2024-10-29 | $4.15M derived: sum of 4 quarters · filed 2024-10-29 | |
| 2023-12-31 | $29.39M derived: 10-Q 12 month − 10-Q 9 month · filed 2024-10-29 | $7.37M derived: sum of 2 quarters · filed 2024-10-29 | $22.61M derived: sum of 3 quarters · filed 2024-10-29 | $36.31M 10-Q · filed 2024-10-29 | |
| 2023-09-30 | -$22.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$6.78M derived: sum of 2 quarters · filed 2023-11-07 | $6.92M 10-Q · filed 2023-11-07 | $46.75M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2023-06-30 | $15.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $28.94M 10-Q · filed 2023-08-03 | $68.77M derived: sum of 3 quarters · filed 2023-11-07 | $35.72M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2023-03-31 | $13.70M 10-Q · filed 2023-05-08 | $53.53M derived: sum of 2 quarters · filed 2023-11-07 | $20.48M derived: sum of 3 quarters · filed 2023-11-07 | ||
| 2022-12-31 | $39.83M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-11-07 | $6.78M derived: sum of 2 quarters · filed 2023-11-07 | -$15.33M 10-Q · filed 2023-11-07 | ||
| 2022-09-30 | -$33.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31 | -$55.16M 10-Q · filed 2022-10-31 | |||
| 2022-06-30 | -$22.11M 10-Q · filed 2022-08-01 | ||||
| 2021-12-31 | -$44.37M 10-Q · filed 2022-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |